Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Moderate quality score of 70/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Solid fundamental quality, though solvency presents a headwind.
Wall Street sentiment is generally neutral. This outlook is strongly supported by highly attractive capital returns, anchored by a strong dividend yield, though free cash flow coverage appears tight.
MPV exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance paired with highly explosive earnings growth (23.1% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 88.6% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $8.2M | -15.8% | — | — | +3.2% | |
| EBITDA | $15.4M | — | -2.9% | — | — | |
| Net Income | $7.0M | -23.3% | +23.9% | — | +4.5% | |
| EPS (Diluted) | $0.65 | -24.1% | +23.1% | +15.4% | +4.0% | |
| Free Cash Flow | $5.0M | -17.3% | — | +4.6% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 94.7% | 90.0% | 89.3% | 87.9% |
| Operating Margin | 88.6% | 89.4% | 77.9% | 84.7% |
| Net Margin | 79.9% | 84.1% | 79.6% | 80.8% |
| FCF Margin | 58.2% | 68.3% | 41.3% | 88.7% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q4'25Latest | — | $0.65 | — | ||
| Q2'25 | — | $0.84 | — | ||
| Q2'24 | — | $0.39 | — | ||
| Q2'24 | — | $0.39 | — | ||
| Q1'24 | — | $0.88 | — | ||
| Q4'23 | — | $0.46 | — | ||
| Q3'23 | — | $0.46 | — | ||
| Q2'23 | — | $0.83 | — |
Total return is -5.5% (1Y), lagging the benchmark by -26.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +4.0% | -3.3% | — |
| 1Y | -5.5% | -26.3% | +7.6% |
| 3YCAGR | +17.6% | -1.3% | +33.8% |
| 5YCAGR | +11.2% | 0.0% | +45.6% |
| 10YCAGR | +6.7% | -6.8% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Barings Participation Investors (MPV) valuation, health, and returns.
Based on peer relative multiples, Barings Participation Investors appears Cheap versus peers compared to industry peers.
Barings Participation Investors has multiple valuation anchors: Peer Relative Fair Value: $20.39. A convergence of these signals offers higher conviction.
Barings Participation Investors displays good financial health with a composite quality score of 70/100, supported by a Altman Z-Score of 2.8 (grey zone), Piotroski F-Score of 2/9, Return on Invested Capital (ROIC) of 5.9%.
Barings Participation Investors pays a 9.4% dividend yield, covered by a 0% payout ratio with 4 years of growth, supplemented by a 0.0% buyback yield.
Barings Participation Investors's current growth trajectory is Decelerating. The company achieved -15.8% 1Y revenue growth and -24.1% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for Barings Participation Investors include: -23.1% 1-year max drawdown. Volatility risk is characterized by a beta of 0.53x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.